[
  {
    "ts": "2026-01-02T08:29:22+00:00",
    "headline": "Cidara Therapeutics (CDTX) Rockets 722% in 2025 on Merck $9.2-Billion Merger",
    "summary": "We recently published 10 Market Stars Behind Millionaire-Making in 2025. Cidara Therapeutics Inc. (NASDAQ:CDTX) is one of the top performers. Cidara Therapeutics climbed by 721.76 percent in 2025, primarily bolstered by its looming merger with Merck for $9.2 billion. In an announcement last November, Cidara Therapeutics Inc. (NASDAQ:CDTX) said that it signed a definitive agreement […]",
    "url": "https://finance.yahoo.com/news/cidara-therapeutics-cdtx-rockets-722-082922307.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "76b35b36-b432-37a4-9dbf-de0c9813c7e5",
      "content": {
        "id": "76b35b36-b432-37a4-9dbf-de0c9813c7e5",
        "contentType": "STORY",
        "title": "Cidara Therapeutics (CDTX) Rockets 722% in 2025 on Merck $9.2-Billion Merger",
        "description": "",
        "summary": "We recently published 10 Market Stars Behind Millionaire-Making in 2025. Cidara Therapeutics Inc. (NASDAQ:CDTX) is one of the top performers. Cidara Therapeutics climbed by 721.76 percent in 2025, primarily bolstered by its looming merger with Merck for $9.2 billion. In an announcement last November, Cidara Therapeutics Inc. (NASDAQ:CDTX) said that it signed a definitive agreement […]",
        "pubDate": "2026-01-02T08:29:22Z",
        "displayTime": "2026-01-02T08:29:22Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/a231423f792dd76d3931f4ec02ab52e7",
          "originalWidth": 768,
          "originalHeight": 430,
          "caption": "Citigroup Inc. (C): Among Incredibly Cheap Dividend Stock to Buy Now",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Pe2LZ3TnbbCY0UCWMH.97g--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/a231423f792dd76d3931f4ec02ab52e7.cf.webp",
              "width": 768,
              "height": 430,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5WP2X6sO7KQe_HGx7HQ.tQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/a231423f792dd76d3931f4ec02ab52e7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/cidara-therapeutics-cdtx-rockets-722-082922307.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cidara-therapeutics-cdtx-rockets-722-082922307.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CDTX"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]